Medicare Enrolled
Dr. Thomas Rosvanis, M.D.
Optician · Monroeville, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rosvanis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosvanis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rosvanis
Dr. Thomas Rosvanis is an optician specialist in Monroeville, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Rosvanis performed 1,704 Medicare services across 1,149 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rosvanis received a total of $11,660 from 53 pharmaceutical and/or device companies across 611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rosvanis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 18% volume in PA
$11,660 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,704
Medicare services
Top 18% in PA for optician
1,149
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
442 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
377 | $56 | $110 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
287 | $61 | $111 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
166 | $87 | $163 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
115 | $7 | $130 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
52 | $0 | $5 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
42 | $133 | $309 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $103 | $250 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
37 | $169 | $393 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
33 | $23 | $108 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
21 | $11 | $45 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
20 | $314 | $832 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $100 | $209 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $103 | $271 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
13 | $157 | $410 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
13 | $44 | $294 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
11 | $232 | $455 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
15.3% medium
82.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,660
Total received (2018-2024)
Avg $1,666/year across 7 years
Top 15% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
611
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,660 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,043
2023
$1,966
2022
$2,676
2021
$1,432
2020
$1,069
2019
$1,481
2018
$992
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$373
Dendreon Pharmaceuticals LLC
$313
Boston Scientific Corporation
$174
Axonics, Inc.
$158
Verity Pharmaceuticals Inc.
$151
PROGENICS PHARMACEUTICALS, INC.
$124
Tolmar, Inc.
$91
COLOPLAST CORP
$88
Antares Pharma, Inc.
$73
Astellas Pharma US Inc
$65
Olympus America Inc.
$45
AstraZeneca Pharmaceuticals LP
$42
Ethicon US, LLC
$41
Endo Pharmaceuticals Inc.
$39
Endo USA, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$33
Merck Sharp & Dohme LLC
$32
UROGEN PHARMA, INC.
$31
Ferring Pharmaceuticals Inc.
$29
Novartis Pharmaceuticals Corporation
$28
IMMUNITYBIO, INC.
$22
PFIZER INC.
$19
Ambu Inc.
$18
Medtronic, Inc.
$17
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,697
Janssen Biotech, Inc.
$1,329
Boston Scientific Corporation
$1,097
Dendreon Pharmaceuticals LLC
$1,026
Sumitomo Pharma America, Inc.
$1,005
Axonics, Inc.
$472
Myovant Sciences Inc.
$431
Bayer HealthCare Pharmaceuticals Inc.
$377
AstraZeneca Pharmaceuticals LP
$340
PFIZER INC.
$340
Myriad Genetic Laboratories, Inc.
$330
Coloplast Corp
$287
Endo Pharmaceuticals Inc.
$208
Verity Pharmaceuticals Inc.
$196
Abbott Laboratories
$189
Medtronic, Inc.
$185
Bayer Healthcare Pharmaceuticals Inc.
$181
COLOPLAST CORP
$160
PROGENICS PHARMACEUTICALS, INC.
$124
Olympus America Inc.
$120
AbbVie, Inc.
$119
UROVANT SCIENCES INC
$106
AbbVie Inc.
$106
Agiliti Surgical, Inc.
$99
Antares Pharma, Inc.
$91
Tolmar, Inc.
$91
Blue Earth Diagnostics Limited
$86
Axonics Modulation Technologies, Inc.
$64
Janssen Scientific Affairs, LLC
$62
Ethicon US, LLC
$61
Metuchen Pharmaceuticals
$58
Supernus Pharmaceuticals, Inc.
$50
UROGEN PHARMA, INC.
$48
ABBVIE INC.
$47
Ferring Pharmaceuticals Inc.
$44
Palette Life Sciences, Inc.
$42
C. R. Bard, Inc. & Subsidiaries
$40
Endo USA, Inc.
$36
DENTSPLY IH Inc.
$34
Merck Sharp & Dohme LLC
$32
Merck Sharp & Dohme Corporation
$32
Novartis Pharmaceuticals Corporation
$28
Augmenix, Inc.
$25
IMMUNITYBIO, INC.
$22
Progenics Pharmaceuticals, Inc.
$20
CONMED Corporation
$19
Ambu Inc.
$18
BOSTON SCIENTIFIC CORPORATION
$17
Aytu BioScience, Inc
$15
Foundation Medicine, Inc.
$14
Clovis Oncology, Inc.
$13
Sagent Pharmaceuticals, Inc.
$12
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 35.4% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · AMS 700 · AMS 700 CXR RTE Kit · ANKTIVA · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BRAC CDx · BRACANALYSIS CDX · Bulkamid · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL THERAPIES · General - Kidney Stone Disease · Glydo · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LYRICA · LoFric · Lupron · Lupron Depot · MALE INCONTINENCE · MYRBETRIQ · Myrbetriq · NEUWAVE Flex Microwave Ablation System · NOCDURNA · Natesto · Nubeqa · ORGOVYX · Olympus · Olympus Cysto-Resection · Olympus Ureteroscopes · PLUVICTO · PRECISETUMOR · PREMARIN · PROCLAIM · PROLARIS · PROVENGE · PYLARIFY · Percutaneous Tract Kit · Prolaris · REZUM · Rezum Generator · Rubraca · SPEEDICATH · STRATAFIX · Solyx SIS System · Sonablate · SpaceOAR · SpeediCath · Stendra · TLANDO · TOVIAZ · Trelstar · URETERO-RENO VIDEOSCOPE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,064
Per 100K population
85.8
County median income
$76,393
Nearest hospital
FORBES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rosvanis is a clinical cardiology specialist, with above-average Medicare volume (top 18% in PA), with low-engagement industry engagement in the top 15% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rosvanis experienced with automated urinalysis?
Based on Medicare claims data, Dr. Rosvanis performed 442 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosvanis receive payments from pharmaceutical companies?
Yes. Dr. Rosvanis received a total of $11,660 from 53 companies across 611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosvanis's costs compare to other opticians in Monroeville?
Dr. Rosvanis's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosvanis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Monroeville
Browse opticians in Monroeville ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology